APO Research
Talk to an analyst

APO RESEARCH · REPORT

DTaP Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global DTaP Vaccine Market Analysis and Forecast 2026-2032

19 December 2025198 pages

Choose your research edition.

Industry ResearchDTaP Vaccine Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal DTaP Vaccine Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal DTaP Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal DTaP Vaccine Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal DTaP Vaccine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global DTaP Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for DTaP Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for DTaP Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for DTaP Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for DTaP Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of DTaP Vaccine include Merck, GlaxoSmithKline and Sanofi Pasteur, Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for DTaP Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of DTaP Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for DTaP Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the DTaP Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global DTaP Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for DTaP Vaccine sales, projected growth trends, production technology, application and end-user industry.

DTaP Vaccine Segment by Company

Merck

GlaxoSmithKline

Sanofi Pasteur, Ltd.

DTaP Vaccine Segment by Type

Immune DTaP Vaccine

Therapy DTaP Vaccine

DTaP Vaccine Segment by Application

Adult

Pediatric

DTaP Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DTaP Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DTaP Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DTaP Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of DTaP Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of DTaP Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, DTaP Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global DTaP Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Immune DTaP Vaccine Major Manufacturers Table 3. Therapy DTaP Vaccine Major Manufacturers Table 4. Global DTaP Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Adult Major Manufacturers Table 6. Pediatric Major Manufacturers Table 7. DTaP Vaccine Industry Trends Table 8. DTaP Vaccine Industry Drivers Table 9. DTaP Vaccine Industry Opportunities and Challenges Table 10. DTaP Vaccine Industry Restraints Table 11. Global DTaP Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global DTaP Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 13. Global DTaP Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 14. Global DTaP Vaccine Revenue Market Share by Region (2021-2026) Table 15. Global DTaP Vaccine Revenue Market Share by Region (2027-2032) Table 16. Global DTaP Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global DTaP Vaccine Sales by Region (2021-2026) & (K Units) Table 18. Global DTaP Vaccine Sales by Region (2027-2032) & (K Units) Table 19. Global DTaP Vaccine Sales Market Share by Region (2021-2026) Table 20. Global DTaP Vaccine Sales Market Share by Region (2027-2032) Table 21. Global DTaP Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global DTaP Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 23. Global DTaP Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global DTaP Vaccine Sales Market Share by Manufacturers (2021-2026) Table 25. Global DTaP Vaccine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global DTaP Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global DTaP Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global DTaP Vaccine Manufacturers, Product Type & Application Table 29. Global DTaP Vaccine Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global DTaP Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global DTaP Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global DTaP Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 34. Global DTaP Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 35. Global DTaP Vaccine Revenue Market Share by Type (2021-2026) Table 36. Global DTaP Vaccine Revenue Market Share by Type (2027-2032) Table 37. Global DTaP Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global DTaP Vaccine Sales by Type (2021-2026) & (K Units) Table 39. Global DTaP Vaccine Sales by Type (2027-2032) & (K Units) Table 40. Global DTaP Vaccine Sales Market Share by Type (2021-2026) Table 41. Global DTaP Vaccine Sales Market Share by Type (2027-2032) Table 42. Global DTaP Vaccine Price by Type (2021-2026) & (US$/Unit) Table 43. Global DTaP Vaccine Price by Type (2027-2032) & (US$/Unit) Table 44. Global DTaP Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global DTaP Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 46. Global DTaP Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 47. Global DTaP Vaccine Revenue Market Share by Application (2021-2026) Table 48. Global DTaP Vaccine Revenue Market Share by Application (2027-2032) Table 49. Global DTaP Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global DTaP Vaccine Sales by Application (2021-2026) & (K Units) Table 51. Global DTaP Vaccine Sales by Application (2027-2032) & (K Units) Table 52. Global DTaP Vaccine Sales Market Share by Application (2021-2026) Table 53. Global DTaP Vaccine Sales Market Share by Application (2027-2032) Table 54. Global DTaP Vaccine Price by Application (2021-2026) & (US$/Unit) Table 55. Global DTaP Vaccine Price by Application (2027-2032) & (US$/Unit) Table 56. Merck Company Information Table 57. Merck Business Overview Table 58. Merck DTaP Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Merck DTaP Vaccine Product Portfolio Table 60. Merck Recent Development Table 61. GlaxoSmithKline Company Information Table 62. GlaxoSmithKline Business Overview Table 63. GlaxoSmithKline DTaP Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. GlaxoSmithKline DTaP Vaccine Product Portfolio Table 65. GlaxoSmithKline Recent Development Table 66. Sanofi Pasteur, Ltd. Company Information Table 67. Sanofi Pasteur, Ltd. Business Overview Table 68. Sanofi Pasteur, Ltd. DTaP Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Sanofi Pasteur, Ltd. DTaP Vaccine Product Portfolio Table 70. Sanofi Pasteur, Ltd. Recent Development Table 71. North America DTaP Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 72. North America DTaP Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 73. North America DTaP Vaccine Sales by Type (2021-2026) & (K Units) Table 74. North America DTaP Vaccine Sales by Type (2027-2032) & (K Units) Table 75. North America DTaP Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 76. North America DTaP Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 77. North America DTaP Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 78. North America DTaP Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 79. North America DTaP Vaccine Sales by Application (2021-2026) & (K Units) Table 80. North America DTaP Vaccine Sales by Application (2027-2032) & (K Units) Table 81. North America DTaP Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 82. North America DTaP Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 83. North America DTaP Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 84. North America DTaP Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 85. North America DTaP Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 86. North America DTaP Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 87. North America DTaP Vaccine Sales by Country (2021-2026) & (K Units) Table 88. North America DTaP Vaccine Sales by Country (2027-2032) & (K Units) Table 89. North America DTaP Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 90. North America DTaP Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 91. United States DTaP Vaccine Revenue (2021-2032) & (US$ Million) Table 92. Canada DTaP Vaccine Revenue (2021-2032) & (US$ Million) Table 93. Europe DTaP Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 94. Europe DTaP Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 95. Europe DTaP Vaccine Sales by Type (2021-2026) & (K Units) Table 96. Europe DTaP Vaccine Sales by Type (2027-2032) & (K Units) Table 97. Europe DTaP Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 98. Europe DTaP Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 99. Europe DTaP Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 100. Europe DTaP Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 101. Europe DTaP Vaccine Sales by Application (2021-2026) & (K Units) Table 102. Europe DTaP Vaccine Sales by Application (2027-2032) & (K Units) Table 103. Europe DTaP Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 104. Europe DTaP Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 105. Europe DTaP Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. Europe DTaP Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 107. Europe DTaP Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 108. Europe DTaP Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 109. Europe DTaP Vaccine Sales by Country (2021-2026) & (K Units) Table 110. Europe DTaP Vaccine Sales by Country (2027-2032) & (K Units) Table 111. Europe DTaP Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 112. Europe DTaP Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 113. Germany DTaP Vaccine Revenue (2021-2032) & (US$ Million) Table 114. France DTaP Vaccine Revenue (2021-2032) & (US$ Million) Table 115. U.K. DTaP Vaccine Revenue (2021-2032) & (US$ Million) Table 116. Italy DTaP Vaccine Revenue (2021-2032) & (US$ Million) Table 117. Netherlands DTaP Vaccine Revenue (2021-2032) & (US$ Million) Table 118. China DTaP Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 119. China DTaP Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 120. China DTaP Vaccine Sales by Type (2021-2026) & (K Units) Table 121. China DTaP Vaccine Sales by Type (2027-2032) & (K Units) Table 122. China DTaP Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 123. China DTaP Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 124. China DTaP Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 125. China DTaP Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 126. China DTaP Vaccine Sales by Application (2021-2026) & (K Units) Table 127. China DTaP Vaccine Sales by Application (2027-2032) & (K Units) Table 128. China DTaP Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 129. China DTaP Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 130. Asia DTaP Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 131. Asia DTaP Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 132. Asia DTaP Vaccine Sales by Type (2021-2026) & (K Units) Table 133. Asia DTaP Vaccine Sales by Type (2027-2032) & (K Units) Table 134. Asia DTaP Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 135. Asia DTaP Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 136. Asia DTaP Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 137. Asia DTaP Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 138. Asia DTaP Vaccine Sales by Application (2021-2026) & (K Units) Table 139. Asia DTaP Vaccine Sales by Application (2027-2032) & (K Units) Table 140. Asia DTaP Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 141. Asia DTaP Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 142. Asia DTaP Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Asia DTaP Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 144. Asia DTaP Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 145. Asia DTaP Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 146. Asia DTaP Vaccine Sales by Country (2021-2026) & (K Units) Table 147. Asia DTaP Vaccine Sales by Country (2027-2032) & (K Units) Table 148. Asia DTaP Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 149. Asia DTaP Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 150. Japan DTaP Vaccine Revenue (2021-2032) & (US$ Million) Table 151. South Korea DTaP Vaccine Revenue (2021-2032) & (US$ Million) Table 152. India DTaP Vaccine Revenue (2021-2032) & (US$ Million) Table 153. Australia DTaP Vaccine Revenue (2021-2032) & (US$ Million) Table 154. China Taiwan DTaP Vaccine Revenue (2021-2032) & (US$ Million) Table 155. Southeast Asia DTaP Vaccine Revenue (2021-2032) & (US$ Million) Table 156. SAMEA DTaP Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 157. SAMEA DTaP Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 158. SAMEA DTaP Vaccine Sales by Type (2021-2026) & (K Units) Table 159. SAMEA DTaP Vaccine Sales by Type (2027-2032) & (K Units) Table 160. SAMEA DTaP Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 161. SAMEA DTaP Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 162. SAMEA DTaP Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 163. SAMEA DTaP Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 164. SAMEA DTaP Vaccine Sales by Application (2021-2026) & (K Units) Table 165. SAMEA DTaP Vaccine Sales by Application (2027-2032) & (K Units) Table 166. SAMEA DTaP Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 167. SAMEA DTaP Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 168. SAMEA DTaP Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 169. SAMEA DTaP Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 170. SAMEA DTaP Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 171. SAMEA DTaP Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 172. SAMEA DTaP Vaccine Sales by Country (2021-2026) & (K Units) Table 173. SAMEA DTaP Vaccine Sales by Country (2027-2032) & (K Units) Table 174. SAMEA DTaP Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 175. SAMEA DTaP Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 176. Brazil DTaP Vaccine Revenue (2021-2032) & (US$ Million) Table 177. Argentina DTaP Vaccine Revenue (2021-2032) & (US$ Million) Table 178. Chile DTaP Vaccine Revenue (2021-2032) & (US$ Million) Table 179. Colombia DTaP Vaccine Revenue (2021-2032) & (US$ Million) Table 180. Peru DTaP Vaccine Revenue (2021-2032) & (US$ Million) Table 181. Saudi Arabia DTaP Vaccine Revenue (2021-2032) & (US$ Million) Table 182. Israel DTaP Vaccine Revenue (2021-2032) & (US$ Million) Table 183. UAE DTaP Vaccine Revenue (2021-2032) & (US$ Million) Table 184. Turkey DTaP Vaccine Revenue (2021-2032) & (US$ Million) Table 185. Iran DTaP Vaccine Revenue (2021-2032) & (US$ Million) Table 186. Egypt DTaP Vaccine Revenue (2021-2032) & (US$ Million) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. DTaP Vaccine Distributors List Table 190. DTaP Vaccine Customers List Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. DTaP Vaccine Image Figure 2. Global DTaP Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global DTaP Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Immune DTaP Vaccine Image Figure 5. Therapy DTaP Vaccine Image Figure 6. Global DTaP Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global DTaP Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Adult Image Figure 9. Pediatric Image Figure 10. Global DTaP Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global DTaP Vaccine Revenue (2021-2032) & (US$ Million) Figure 12. Global DTaP Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global DTaP Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global DTaP Vaccine Revenue Market Share by Region (2021-2032) Figure 15. Global DTaP Vaccine Sales (2021-2032) & (K Units) Figure 16. Global DTaP Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global DTaP Vaccine Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico DTaP Vaccine Sales YoY (2021-2032) & (K Units) Figure 19. Europe DTaP Vaccine Sales YoY (2021-2032) & (K Units) Figure 20. China DTaP Vaccine Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) DTaP Vaccine Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa DTaP Vaccine Sales YoY (2021-2032) & (K Units) Figure 23. Global DTaP Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global DTaP Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global DTaP Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global DTaP Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global DTaP Vaccine Revenue Market Share by Type (2021-2032) Figure 29. Global DTaP Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global DTaP Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global DTaP Vaccine Sales Market Share by Type (2021-2032) Figure 32. Global DTaP Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global DTaP Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global DTaP Vaccine Revenue Market Share by Application (2021-2032) Figure 35. Global DTaP Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global DTaP Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global DTaP Vaccine Sales Market Share by Application (2021-2032) Figure 38. North America DTaP Vaccine Revenue Share by Type (2021-2032) Figure 39. North America DTaP Vaccine Sales Share by Type (2021-2032) Figure 40. North America DTaP Vaccine Revenue Share by Application (2021-2032) Figure 41. North America DTaP Vaccine Sales Share by Application (2021-2032) Figure 42. North America DTaP Vaccine Revenue Share by Country (2021-2032) Figure 43. North America DTaP Vaccine Sales Share by Country (2021-2032) Figure 44. Europe DTaP Vaccine Revenue Share by Type (2021-2032) Figure 45. Europe DTaP Vaccine Sales Share by Type (2021-2032) Figure 46. Europe DTaP Vaccine Revenue Share by Application (2021-2032) Figure 47. Europe DTaP Vaccine Sales Share by Application (2021-2032) Figure 48. Europe DTaP Vaccine Revenue Share by Country (2021-2032) Figure 49. Europe DTaP Vaccine Sales Share by Country (2021-2032) Figure 50. China DTaP Vaccine Revenue Share by Type (2021-2032) Figure 51. China DTaP Vaccine Sales Share by Type (2021-2032) Figure 52. China DTaP Vaccine Revenue Share by Application (2021-2032) Figure 53. China DTaP Vaccine Sales Share by Application (2021-2032) Figure 54. Asia DTaP Vaccine Revenue Share by Type (2021-2032) Figure 55. Asia DTaP Vaccine Sales Share by Type (2021-2032) Figure 56. Asia DTaP Vaccine Revenue Share by Application (2021-2032) Figure 57. Asia DTaP Vaccine Sales Share by Application (2021-2032) Figure 58. Asia DTaP Vaccine Revenue Share by Country (2021-2032) Figure 59. Asia DTaP Vaccine Sales Share by Country (2021-2032) Figure 60. SAMEA DTaP Vaccine Revenue Share by Type (2021-2032) Figure 61. SAMEA DTaP Vaccine Sales Share by Type (2021-2032) Figure 62. SAMEA DTaP Vaccine Revenue Share by Application (2021-2032) Figure 63. SAMEA DTaP Vaccine Sales Share by Application (2021-2032) Figure 64. SAMEA DTaP Vaccine Revenue Share by Country (2021-2032) Figure 65. SAMEA DTaP Vaccine Sales Share by Country (2021-2032) Figure 66. DTaP Vaccine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. DTaP Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Immune DTaP Vaccine
  • Therapy DTaP Vaccine
Applications
  • Adult
  • Pediatric
Companies covered
  • Merck
  • GlaxoSmithKline
  • Sanofi Pasteur, Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 DTaP Vaccine Market by Type
  3. 1.2.1 Global DTaP Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Immune DTaP Vaccine
  5. 1.2.3 Therapy DTaP Vaccine
  6. 1.3 DTaP Vaccine Market by Application
  7. 1.3.1 Global DTaP Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Adult
  9. 1.3.3 Pediatric
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 DTaP Vaccine Market Dynamics
  1. 2.1 DTaP Vaccine Industry Trends
  2. 2.2 DTaP Vaccine Industry Drivers
  3. 2.3 DTaP Vaccine Industry Opportunities and Challenges
  4. 2.4 DTaP Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global DTaP Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global DTaP Vaccine Revenue by Region
  3. 3.2.1 Global DTaP Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global DTaP Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global DTaP Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global DTaP Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global DTaP Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global DTaP Vaccine Sales by Region
  9. 3.4.1 Global DTaP Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global DTaP Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global DTaP Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global DTaP Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global DTaP Vaccine Revenue by Manufacturers
  2. 4.1.1 Global DTaP Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global DTaP Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global DTaP Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global DTaP Vaccine Sales by Manufacturers
  6. 4.2.1 Global DTaP Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global DTaP Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global DTaP Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global DTaP Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global DTaP Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global DTaP Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global DTaP Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global DTaP Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global DTaP Vaccine Market CR5 and HHI
  16. 4.8.2 2025 DTaP Vaccine Tier 1, Tier 2, and Tier 3
5 DTaP Vaccine Market by Type
  1. 5.1 Global DTaP Vaccine Revenue by Type
  2. 5.1.1 Global DTaP Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global DTaP Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global DTaP Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global DTaP Vaccine Sales by Type
  6. 5.2.1 Global DTaP Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global DTaP Vaccine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global DTaP Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global DTaP Vaccine Price by Type
6 DTaP Vaccine Market by Application
  1. 6.1 Global DTaP Vaccine Revenue by Application
  2. 6.1.1 Global DTaP Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global DTaP Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global DTaP Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global DTaP Vaccine Sales by Application
  6. 6.2.1 Global DTaP Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global DTaP Vaccine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global DTaP Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global DTaP Vaccine Price by Application
7 Company Profiles
  1. 7.1 Merck
  2. 7.1.1 Merck Company Information
  3. 7.1.2 Merck Business Overview
  4. 7.1.3 Merck DTaP Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Merck DTaP Vaccine Product Portfolio
  6. 7.1.5 Merck Recent Developments
  7. 7.2 GlaxoSmithKline
  8. 7.2.1 GlaxoSmithKline Company Information
  9. 7.2.2 GlaxoSmithKline Business Overview
  10. 7.2.3 GlaxoSmithKline DTaP Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 GlaxoSmithKline DTaP Vaccine Product Portfolio
  12. 7.2.5 GlaxoSmithKline Recent Developments
  13. 7.3 Sanofi Pasteur, Ltd.
  14. 7.3.1 Sanofi Pasteur, Ltd. Company Information
  15. 7.3.2 Sanofi Pasteur, Ltd. Business Overview
  16. 7.3.3 Sanofi Pasteur, Ltd. DTaP Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sanofi Pasteur, Ltd. DTaP Vaccine Product Portfolio
  18. 7.3.5 Sanofi Pasteur, Ltd. Recent Developments
8 North America
  1. 8.1 North America DTaP Vaccine Market Size by Type
  2. 8.1.1 North America DTaP Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America DTaP Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America DTaP Vaccine Price by Type (2021-2032)
  5. 8.2 North America DTaP Vaccine Market Size by Application
  6. 8.2.1 North America DTaP Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America DTaP Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America DTaP Vaccine Price by Application (2021-2032)
  9. 8.3 North America DTaP Vaccine Market Size by Country
  10. 8.3.1 North America DTaP Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America DTaP Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America DTaP Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe DTaP Vaccine Market Size by Type
  2. 9.1.1 Europe DTaP Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe DTaP Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe DTaP Vaccine Price by Type (2021-2032)
  5. 9.2 Europe DTaP Vaccine Market Size by Application
  6. 9.2.1 Europe DTaP Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe DTaP Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe DTaP Vaccine Price by Application (2021-2032)
  9. 9.3 Europe DTaP Vaccine Market Size by Country
  10. 9.3.1 Europe DTaP Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe DTaP Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe DTaP Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China DTaP Vaccine Market Size by Type
  2. 10.1.1 China DTaP Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China DTaP Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China DTaP Vaccine Price by Type (2021-2032)
  5. 10.2 China DTaP Vaccine Market Size by Application
  6. 10.2.1 China DTaP Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China DTaP Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China DTaP Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia DTaP Vaccine Market Size by Type
  2. 11.1.1 Asia DTaP Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia DTaP Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia DTaP Vaccine Price by Type (2021-2032)
  5. 11.2 Asia DTaP Vaccine Market Size by Application
  6. 11.2.1 Asia DTaP Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia DTaP Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia DTaP Vaccine Price by Application (2021-2032)
  9. 11.3 Asia DTaP Vaccine Market Size by Country
  10. 11.3.1 Asia DTaP Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia DTaP Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia DTaP Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA DTaP Vaccine Market Size by Type
  2. 12.1.1 SAMEA DTaP Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA DTaP Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA DTaP Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA DTaP Vaccine Market Size by Application
  6. 12.2.1 SAMEA DTaP Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA DTaP Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA DTaP Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA DTaP Vaccine Market Size by Country
  10. 12.3.1 SAMEA DTaP Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA DTaP Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA DTaP Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 DTaP Vaccine Value Chain Analysis
  2. 13.1.1 DTaP Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 DTaP Vaccine Production Mode & Process
  6. 13.2 DTaP Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 DTaP Vaccine Distributors
  9. 13.2.3 DTaP Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst